Hong S, Kim WJ, Kim S, Park JH, et al. Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study). Diabetes Obes Metab 2025 Nov 5. doi: 10.1111/dom.70258.
PMID: 41190361